These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 8405091

  • 1. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
    Miyamoto M, Hirai K, Takahashi H, Kato K, Nishiyama M, Okada H, Nagaoka A.
    Eur J Pharmacol; 1993 Jul 20; 238(2-3):181-9. PubMed ID: 8405091
    [Abstract] [Full Text] [Related]

  • 2. Effects of a sustained release formulation of thyrotropin-releasing hormone on behavioral abnormalities in senescence-accelerated mice.
    Miyamoto M, Hirai K, Heya T, Nagaoka A.
    Eur J Pharmacol; 1994 Dec 27; 271(2-3):357-66. PubMed ID: 7705436
    [Abstract] [Full Text] [Related]

  • 3. Effects of nefiracetam on deficits in active avoidance response and hippocampal cholinergic and monoaminergic dysfunctions induced by AF64A in mice.
    Abe E, Murai S, Saito H, Masuda Y, Takasu Y, Shiotani T, Tachizawa H, Itoh T.
    J Neural Transm Gen Sect; 1994 Dec 27; 95(3):179-93. PubMed ID: 7865174
    [Abstract] [Full Text] [Related]

  • 4. Effects of intracerebroventricular injection of AF64A on learning behaviors in rats.
    Nakahara N, Iga Y, Mizobe F, Kawanishi G.
    Jpn J Pharmacol; 1988 Sep 27; 48(1):121-30. PubMed ID: 3199599
    [Abstract] [Full Text] [Related]

  • 5. Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats.
    Yamazaki N, Kato K, Kurihara E, Nagaoka A.
    Psychopharmacology (Berl); 1991 Sep 27; 103(2):215-22. PubMed ID: 2027921
    [Abstract] [Full Text] [Related]

  • 6. Impairments of learning and memory following intracerebroventricular administration of AF64A in rats.
    Lim DK, Oh YH, Kim HS.
    Arch Pharm Res; 2001 Jun 27; 24(3):234-9. PubMed ID: 11440084
    [Abstract] [Full Text] [Related]

  • 7. Amelioration of experimental amnesia (passive avoidance failure) in rodents by the selective M1 agonist AF102B.
    Nakahara N, Iga Y, Mizobe F, Kawanishi G.
    Jpn J Pharmacol; 1988 Dec 27; 48(4):502-6. PubMed ID: 3244205
    [Abstract] [Full Text] [Related]

  • 8. Ganglioside AGF2 promotes task-specific recovery and attenuates the cholinergic hypofunction induced by AF64A.
    Emerich DF, Walsh TJ.
    Brain Res; 1990 Sep 17; 527(2):299-307. PubMed ID: 2253037
    [Abstract] [Full Text] [Related]

  • 9. Beneficial effects of FKS-508 (AF102B), a selective M1 agonist, on the impaired working memory in AF64A-treated rats.
    Nakahara N, Iga Y, Saito Y, Mizobe F, Kawanishi G.
    Jpn J Pharmacol; 1989 Dec 17; 51(4):539-47. PubMed ID: 2615046
    [Abstract] [Full Text] [Related]

  • 10. Protective effect of WEB 1881 FU on AF64A (ethylcholine aziridinium ion)-induced impairment of hippocampal cholinergic neurons and learning acquisition.
    Hashimoto M, Hashimoto T, Kuriyama K.
    Eur J Pharmacol; 1991 Dec 10; 209(1-2):9-14. PubMed ID: 1814764
    [Abstract] [Full Text] [Related]

  • 11. Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
    Vickroy TW, Watson M, Leventer SM, Roeske WR, Hanin I, Yamamura HI.
    J Pharmacol Exp Ther; 1985 Dec 10; 235(3):577-82. PubMed ID: 3841155
    [Abstract] [Full Text] [Related]

  • 12. Learning deficits after unilateral AF64A lesions in the rat basal forebrain: role of cholinergic and noncholinergic systems.
    Nakamura S, Tani Y, Maezono Y, Ishihara T, Ohno T.
    Pharmacol Biochem Behav; 1992 May 10; 42(1):119-30. PubMed ID: 1528935
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (IV): Effects on experimental memory impairment in mice and rats.
    Yamamura M, Kinoshita K, Nakagawa H, Ishida R.
    Jpn J Pharmacol; 1991 Feb 10; 55(2):241-53. PubMed ID: 1906119
    [Abstract] [Full Text] [Related]

  • 14. The histopathological, behavioral and neurochemical effects of intraventricular injection of ethylcholine mustard aziridinium (AF64A) in the neonatal rat.
    Armstrong JN, Pappas BA.
    Brain Res Dev Brain Res; 1991 Aug 19; 61(2):249-57. PubMed ID: 1752043
    [Abstract] [Full Text] [Related]

  • 15. Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions.
    Mouton PR, Meyer EM, Dunn AJ, Millard W, Arendash GW.
    Brain Res; 1988 Mar 15; 444(1):104-18. PubMed ID: 3359282
    [Abstract] [Full Text] [Related]

  • 16. Dose- and delay-dependent working/episodic memory impairments following intraventricular administration of ethylcholine aziridinium ion (AF64A).
    Chrobak JJ, Walsh TJ.
    Behav Neural Biol; 1991 Sep 15; 56(2):200-12. PubMed ID: 1759941
    [Abstract] [Full Text] [Related]

  • 17. Nicotine improves AF64A-induced spatial memory deficits in Morris water maze in rats.
    Yamada K, Furukawa S, Iwasaki T, Ichitani Y.
    Neurosci Lett; 2010 Jan 18; 469(1):88-92. PubMed ID: 19941937
    [Abstract] [Full Text] [Related]

  • 18. Alpha-sialyl cholesterol reverses AF64A-induced deficit in passive avoidance response and depletion of hippocampal acetylcholine in mice.
    Abe E, Murai S, Masuda Y, Saito H, Itoh T.
    Br J Pharmacol; 1993 Feb 18; 108(2):387-92. PubMed ID: 8448588
    [Abstract] [Full Text] [Related]

  • 19. Effects of physostigmine on AF64A-induced impairment of learning acquisition in rats.
    Ogura H, Yamanishi Y, Yamatsu K.
    Jpn J Pharmacol; 1987 Aug 18; 44(4):498-501. PubMed ID: 3682413
    [Abstract] [Full Text] [Related]

  • 20. Effect of thyrotropin-releasing hormone on pentobarbitone-induced sleep in rats: continuous treatment with a sustained release injectable formulation.
    Hashimoto T, Wada T, Fukuda N, Nagaoka A.
    J Pharm Pharmacol; 1993 Feb 18; 45(2):94-7. PubMed ID: 8095539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.